Celltrion Gains Approval for Biosimilars in Japan
Celltrion announced it has received product approval from the Japanese Ministry of Health, Labor and Welfare for Omlyclo and Eydenzelt, two biosimilars for allergic and ophthalmic diseases, respectively.